17 min

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19 Coronavirus (COVID-19) Q&A

    • Medicine

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

17 min

More by JAMA Network

JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Author Interviews
JAMA Network
JAMAevidence The Rational Clinical Examination
JAMA Network